Quarterly Transactions Made in Ars Pharmaceuticals, Inc. Comm (SPRY)
This table provides information about the institutional ownership of Ars Pharmaceuticals, Inc. Comm (SPRY). The information is specifically focused on institutions that hold shares of ARS PHARMACEUTICALS, INC. COMM.
Shares Purchased
Shares Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q4 2020 | 0 | 20,094,906 | 20,094,906 | — | 20,094,906 | |||
| Q1 2021 | 315,376 | 1,116,770 | 1,432,146 | 506,681 | 586,999 | 1,093,680 | 338,466 | |
| Q2 2021 | 1,292,942 | 5,086,346 | 6,379,288 | 446,330 | 281,637 | 727,967 | 5,651,321 | |
| Q3 2021 | 1,381,473 | 1,906,236 | 3,287,709 | 1,957,188 | 2,442,400 | 4,399,588 | -1,111,879 | |
| Q4 2021 | 2,504,034 | 3,052,502 | 5,556,536 | 957,564 | 2,920,592 | 3,878,156 | 1,678,380 | |
| Q1 2022 | 2,609,484 | 263,058 | 2,872,542 | 2,738,200 | 2,146,703 | 4,884,903 | -2,012,361 | |
| Q2 2022 | 914,083 | 4,027,421 | 4,941,504 | 1,673,550 | 3,950,260 | 5,623,810 | -682,306 | |
| Q3 2022 | 4,780,148 | 2,443,879 | 7,224,027 | 1,770,752 | 0 | 1,770,752 | 5,453,275 | |